TIACA and Pharma.Aero jointly release their second report for the global air cargo and pharmaceutical industries outlining recommended practices and insights for effective COVID-19 vaccine air transportation and handling.
The report reinforces that COVID-19 vaccines are of high value and urgent time and temperature sensitive products.
As the vaccines are being transported across the globe, it is apparent that the challenge of COVID-19 vaccine global distribution demands the highest standards of Speed, Security, Reliability and Transparency.
“To this end, open communication and air cargo community collaboration are paramount,” stated Nathan De Valck, Chairman of Pharma.Aero.
The report details the role and recommended practices for each stakeholder in the air cargo supply chain when addressing the four major requirements identified.
Both TIACA and Pharma.Aero encourage the industry to adopt a local air cargo community approach in executing these specific requirements.
